IAM
ABEV icon

Infusive Asset Management’s Ambev ABEV Stock Holding History

Infusive Asset Management’s Portfolio ABEV Stock Details ABEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-43,158
Closed -$118K – 56
2021
Q1 		$118K Buy
43,158
+5,166
+14% +$14.6K 0.03% 55
2020
Q4 		$116K Buy
+37,992
New +$102K 0.04% 48

Other funds holding ABEV

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SIM
Sprucegrove Investment Management Toronto, Ontario, Canada $639M AUM 23.31% 1-Year Est. Return
RL
Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return
WGI
Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Infusive Asset Management's ABEV Position: Q2 2021 in Review

Infusive Asset Management sold out of Ambev (ABEV) in Q2 2021, closing a stake of 43,158 shares — an estimated $118K sold.

Infusive Asset Management first reported a position in ABEV in Q4 2020 and held it in 2 quarters. The position peaked at $118K in Q1 2021. 280 funds tracked by Wall St. Rank hold ABEV as of Q2 2021.

  • Infusive Asset Management reported no remaining Ambev position as of Q2 2021 after selling out during the quarter.
  • Infusive Asset Management sold 43,158 Ambev shares in Q2 2021, an estimated $118K.
  • Infusive Asset Management first reported a position in Ambev in Q4 2020 and held it in 2 quarters.
  • Infusive Asset Management's Ambev position peaked at $118K in Q1 2021.
  • 280 funds tracked by Wall St. Rank held Ambev as of Q2 2021.

Based on Infusive Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.